Equities

Biofrontera Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
BFRI:NAQ

Biofrontera Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)0.8599
  • Today's Change-0.070 / -7.54%
  • Shares traded3.25k
  • 1 Year change-25.23%
  • Beta0.6249
Data delayed at least 15 minutes, as of Feb 19 2026 20:59 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2024202420232022
ASSETS
Cash And Short Term Investments5.911.4228
Total Receivables, Net5.325.167.41
Total Inventory6.65117.17
Prepaid expenses0.530.310.44
Other current assets, total2.305.280.29
Total current assets212343
Property, plant & equipment, net0.981.751.58
Goodwill, net------
Intangibles, net0.042.633.03
Long term investments------
Note receivable - long term----2.81
Other long term assets0.380.480.32
Total assets222851
LIABILITIES
Accounts payable7.209.012.59
Accrued expenses4.214.4911
Notes payable/short-term debt03.900
Current portion long-term debt/capital leases------
Other current liabilities, total0.610.697.31
Total current liabilities121821
Total long term debt4.1000
Total debt4.103.900
Deferred income tax------
Minority interest------
Other liabilities, total1.555.056.11
Total liabilities182327
SHAREHOLDERS EQUITY
Common stock0.010.000.03
Additional paid-in capital122104103
Retained earnings (accumulated deficit)(117)(100)(80)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity4.434.7924
Total liabilities & shareholders' equity222851
Total common shares outstanding8.871.521.33
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.